These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 29649104)
1. Coordination of GPR40 and Ketogenesis Signaling by Medium Chain Fatty Acids Regulates Beta Cell Function. Pujol JB; Christinat N; Ratinaud Y; Savoia C; Mitchell SE; Dioum EHM Nutrients; 2018 Apr; 10(4):. PubMed ID: 29649104 [TBL] [Abstract][Full Text] [Related]
2. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats. Gowda N; Dandu A; Singh J; Biswas S; Raghav V; Lakshmi MN; Shilpa PC; Sunil V; Reddy A; Sadasivuni M; Aparna K; Verma MK; Moolemath Y; Anup MO; Venkataranganna MV; Somesh BP; Jagannath MR BMC Pharmacol Toxicol; 2013 May; 14():28. PubMed ID: 23692921 [TBL] [Abstract][Full Text] [Related]
3. H₂O₂-Activated Mitochondrial Phospholipase iPLA₂γ Prevents Lipotoxic Oxidative Stress in Synergy with UCP2, Amplifies Signaling via G-Protein-Coupled Receptor GPR40, and Regulates Insulin Secretion in Pancreatic β-Cells. Ježek J; Dlasková A; Zelenka J; Jabůrek M; Ježek P Antioxid Redox Signal; 2015 Oct; 23(12):958-72. PubMed ID: 25925080 [TBL] [Abstract][Full Text] [Related]
4. TAK-875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β-cell dysfunction in Zucker diabetic fatty rats. Ito R; Tsujihata Y; Matsuda-Nagasumi K; Mori I; Negoro N; Takeuchi K Br J Pharmacol; 2013 Oct; 170(3):568-80. PubMed ID: 23848179 [TBL] [Abstract][Full Text] [Related]
5. Long-term in vitro treatment of INS-1 rat pancreatic β-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptors. Tuo Y; Feng DD; Wang DF; Sun J; Li SB; Chen C Clin Exp Pharmacol Physiol; 2012 May; 39(5):423-8. PubMed ID: 22332921 [TBL] [Abstract][Full Text] [Related]
6. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats. Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of Glucose-stimulated Insulin Secretion by the GPR40-PLC-TRPC Pathway in Pancreatic β-Cells. Yamada H; Yoshida M; Ito K; Dezaki K; Yada T; Ishikawa SE; Kakei M Sci Rep; 2016 May; 6():25912. PubMed ID: 27180622 [TBL] [Abstract][Full Text] [Related]
8. The relationship between GPR40 and lipotoxicity of the pancreatic β-cells as well as the effect of pioglitazone. Wu P; Yang L; Shen X Biochem Biophys Res Commun; 2010 Dec; 403(1):36-9. PubMed ID: 21036144 [TBL] [Abstract][Full Text] [Related]
10. Modulating GPR40: therapeutic promise and potential in diabetes. Poitout V; Lin DC Drug Discov Today; 2013 Dec; 18(23-24):1301-8. PubMed ID: 24051395 [TBL] [Abstract][Full Text] [Related]
11. G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell. Morgan NG; Dhayal S Biochem Pharmacol; 2009 Dec; 78(12):1419-27. PubMed ID: 19660440 [TBL] [Abstract][Full Text] [Related]
12. Beta-Hydroxybutyrate (BHB), Glucose, Insulin, Octanoate (C8), and Decanoate (C10) Responses to a Medium-Chain Triglyceride (MCT) Oil with and without Glucose: A Single-Center Study in Healthy Adults. Heidt C; Fobker M; Newport M; Feldmann R; Fischer T; Marquardt T Nutrients; 2023 Feb; 15(5):. PubMed ID: 36904147 [TBL] [Abstract][Full Text] [Related]
13. Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketone body shuttle systems. Thevenet J; De Marchi U; Domingo JS; Christinat N; Bultot L; Lefebvre G; Sakamoto K; Descombes P; Masoodi M; Wiederkehr A FASEB J; 2016 May; 30(5):1913-26. PubMed ID: 26839375 [TBL] [Abstract][Full Text] [Related]
15. Free fatty acid receptor 1 as a novel therapeutic target for type 2 diabetes mellitus-current status. Eleazu C; Charles A; Eleazu K; Achi N Chem Biol Interact; 2018 Jun; 289():32-39. PubMed ID: 29704509 [TBL] [Abstract][Full Text] [Related]
16. Increased glucose metabolism and glycerolipid formation by fatty acids and GPR40 receptor signaling underlies the fatty acid potentiation of insulin secretion. El-Azzouny M; Evans CR; Treutelaar MK; Kennedy RT; Burant CF J Biol Chem; 2014 May; 289(19):13575-88. PubMed ID: 24675078 [TBL] [Abstract][Full Text] [Related]
17. Palmitic acid-induced lipotoxicity promotes a novel interplay between Akt-mTOR, IRS-1, and FFAR1 signaling in pancreatic β-cells. Marafie SK; Al-Shawaf EM; Abubaker J; Arefanian H Biol Res; 2019 Aug; 52(1):44. PubMed ID: 31426858 [TBL] [Abstract][Full Text] [Related]
18. Hexanoic, Octanoic and Decanoic Acids Promote Basal and Insulin-Induced Phosphorylation of the Akt-mTOR Axis and a Balanced Lipid Metabolism in the HepG2 Hepatoma Cell Line. Rial SA; Ravaut G; Malaret TB; Bergeron KF; Mounier C Molecules; 2018 Sep; 23(9):. PubMed ID: 30208604 [TBL] [Abstract][Full Text] [Related]
19. Vincamine as a GPR40 agonist improves glucose homeostasis in type 2 diabetic mice. Du T; Yang L; Xu X; Shi X; Xu X; Lu J; Lv J; Huang X; Chen J; Wang H; Ye J; Hu L; Shen X J Endocrinol; 2019 Feb; 240(2):195-214. PubMed ID: 30400036 [TBL] [Abstract][Full Text] [Related]
20. [A New Pain Regulatory System via the Brain Long Chain Fatty Acid Receptor GPR40/FFA1 Signal]. Nakamoto K Yakugaku Zasshi; 2017; 137(2):199-204. PubMed ID: 28154332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]